The C-Met-dependent PARP1 phosphorylation at Tyr907 increases PARP1 activity and results in a reduced affinity to PARP inhibitors, thereby rendering cancer cells resistant to PARP inhibitors. The gene discussed is PARP1; the disease is cancer.